QGEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Qiagen NV is not a strong buy for a beginner, long-term investor at this time. While the company has shown solid financial growth in Q4 2025, the technical indicators suggest a bearish trend, and hedge funds are selling the stock. Additionally, there are no strong proprietary trading signals or significant positive catalysts to justify immediate action.
The stock is in a bearish trend with MACD negatively expanding (-0.639), RSI indicating oversold conditions (17.176), and the pre-market price ($48.855) nearing the key support level (S1: 48.67). Moving averages are converging, signaling indecision in price direction.
Analysts have raised price targets, with some maintaining Overweight ratings. Management reaffirmed long-term growth targets and indicated openness to M&A opportunities.
Gross margin dropped (-6.94% YoY), hedge funds are selling heavily (+286.76% increase in selling), and the stock has a history of takeover speculation, creating skepticism about fundamental performance. Additionally, the MACD and RSI indicate bearish momentum.
In Q4 2025, Qiagen reported revenue of $540.42M (+3.69% YoY), net income of $107.83M (+22.09% YoY), and EPS of $0.49 (+28.95% YoY). However, gross margin declined to 59.77% (-6.94% YoY).
Analysts have mixed views. Price targets range from $50 to $60, with some firms maintaining Neutral or Hold ratings, while others see potential upside with Overweight ratings. Concerns about the company's base business growth and reliance on M&A have been noted.
